Literature DB >> 32219604

Expression of HIF-2a in clear-cell renal cell carcinoma independently predicts overall survival.

Konstantinos Gkagkalidis1,2,3, Spyridon Kampantais4,5, Georgios Dimitriadis4, Victoras Gourvas6, Dorothea Kapoukranidou7, Maria Mironidou-Tzouveleki8.   

Abstract

The purpose of this study is to evaluate the expression and the prognostic role of main factors, involved in the hypoxia pathway, in patients with clear-cell renal cell carcinoma (ccRCC). Immunohistochemical expression of Hypoxia inducible factors (HIF) HIF-1a, HIF-2a, prolyl hydroxylases PHD1, PHD2, PHD3, and factor inhibiting HIF (FIH) was assessed on a tissue microarray, containing tumour and corresponding normal kidney tissue from 66 patients underwent surgery for ccRCC. Expression levels were evaluated in relation to T stage, Fuhrman grade, cancer-specific, and overall survival (OS). Cytoplasmatic expression of HIF-2a was positively correlated with expression of HIF-1a (p = 0.011). HIF-1a expression was also positively correlated with PHD3 and FIH (p = 0.020 and p = 0.039). Expression of HIF-1a was associated with lower Fuhrman grade (p = 0.008), while HIF-2a overexpression with unfavourable grade (p = 0.026). PHD3 was significant downregulated (84.8%). Age, LDH, presence of necrosis, Fuhrman grade, T stage, and HIF-2a cytoplasmatic expression were significant associated with OS of patients in univariable analysis. In multivariable analysis, HIF-2a expression (p = 0.006) and T stage (p = 0.001) remained as the only independent predictors for overall survival. These results indicate that HIF-2a overexpression not only is inversely correlated with Fuhrman grade in ccRCC, but also represents a strong independent prognostic factor for a poor overall survival.

Entities:  

Keywords:  Clear cell renal cell carcinoma; FIH; HIF; Hypoxia; PHD; Prognostic marker

Mesh:

Substances:

Year:  2020        PMID: 32219604     DOI: 10.1007/s00795-020-00249-3

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  6 in total

1.  TXNIP knockout improves cardiac function after myocardial infarction by promoting angiogenesis and reducing cardiomyocyte apoptosis.

Authors:  Jin Wang; Xue-Jiao Wang; Yan Zhang; Wen-Juan Shi; Zhan-Dong Lei; Xiang-Ying Jiao
Journal:  Cardiovasc Diagn Ther       Date:  2022-06

Review 2.  Hypoxia-Induced circRNAs in Human Diseases: From Mechanisms to Potential Applications.

Authors:  Qi Huang; Juan Yang; Robby Miguel Wen-Jing Goh; Mingliang You; Lingzhi Wang; Zhaowu Ma
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

3.  Loss of Heterozygosity for KrasG12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism.

Authors:  Yu Ma; Sunkai Ling; Yuan Li; Mingyue Hu; Bo Kong; Peilin Huang; Hui Liu
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

4.  A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma.

Authors:  Jiahao Gao; Fangdie Ye; Fang Han; Xiaoshuang Wang; Haowen Jiang; Jiawen Zhang
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

Review 5.  Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy.

Authors:  Leah Davis; Matthias Recktenwald; Evan Hutt; Schuyler Fuller; Madison Briggs; Arnav Goel; Nichole Daringer
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

Review 6.  Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma.

Authors:  Ieman A M Aljahdali; Renyuan Zhang; Fengzhi Li; Kent L Nastiuk; John J Krolewski; Xiang Ling
Journal:  J Exp Clin Cancer Res       Date:  2021-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.